PHARMACEUTICAL COMPOSITIONS
Described herein are compositions that can include Compound 1 or Form J of Compound 1, or a pharmaceutically acceptable salt of the aforementioned compounds. Also, described herein is a method of treating a HCV infection in a subject that can include administering to the subject a composition that i...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English French |
Published |
04.09.2014
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Described herein are compositions that can include Compound 1 or Form J of Compound 1, or a pharmaceutically acceptable salt of the aforementioned compounds. Also, described herein is a method of treating a HCV infection in a subject that can include administering to the subject a composition that includes Compound 1 or Form J of Compound 1, or a pharmaceutically acceptable salt of the aforementioned compounds.
La présente invention concerne des compositions qui peuvent comprendre un composé 1 ou une forme J du composé 1, ou un sel pharmaceutiquement acceptable des composés mentionnés précédemment. L'invention concerne également une méthode de traitement d'une infection par le VHC d'un sujet qui peut faire appel à l'administration, au sujet, d'une composition qui comprend le composé 1 ou la forme J du composé 1, ou un sel pharmaceutiquement acceptable des composés mentionnés précédemment. |
---|---|
Bibliography: | Application Number: WO2014US18863 |